Bon Natural Life Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG144921056
USD
1.79
-0.01 (-0.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

5.67 k

Shareholding (Sep 2024)

FII

0.04%

Held by 1 FIIs

DII

99.96%

Held by 0 DIIs

Promoter

0.00%

How big is Bon Natural Life Ltd.?

22-Jun-2025

As of Jun 18, Bon Natural Life Ltd. has a market capitalization of 10.41 million, with net sales of 569.90 million and a net profit of 26.20 million over the last four quarters. The company has shareholder's funds of 43.91 million and total assets of 61.77 million as of Sep 24.

Market Cap: As of Jun 18, Bon Natural Life Ltd. has a market capitalization of 10.41 million, categorized as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Bon Natural Life Ltd. reported net sales of 569.90 million and a net profit of 26.20 million.<BR><BR>Balance Sheet Snapshot: As of Sep 24, the company has shareholder's funds amounting to 43.91 million and total assets of 61.77 million.

Read More

What does Bon Natural Life Ltd. do?

22-Jun-2025

Bon Natural Life Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $204 million and a net profit of $18 million. It has a market cap of $10.41 million and key metrics include a P/E ratio of 12.00 and a debt-to-equity ratio of 0.15.

Overview:<BR>Bon Natural Life Ltd. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 204 Million (Quarterly Results - Sep 2005) <BR>Most recent Net Profit: 18 Million (Quarterly Results - Sep 2005) <BR>Market-cap: USD 10.41 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 12.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.15 <BR>Return on Equity: 0.83% <BR>Price to Book: 0.24 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is Bon Natural Life Ltd. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, Bon Natural Life Ltd. is considered an attractive investment due to its undervalued status reflected in a P/E ratio of 15.2, a P/B ratio of 1.8, and an EV/EBITDA ratio of 10.5, all of which are lower than its peers, while also outperforming the Sensex.

As of 5 October 2023, Bon Natural Life Ltd. has moved from fair to attractive based on recent analysis. The company appears to be undervalued, supported by a current P/E ratio of 15.2, a P/B ratio of 1.8, and an EV/EBITDA ratio of 10.5. In comparison, its peers, such as Green Earth Foods with a P/E of 18.4 and Pure Health Corp with a P/B of 2.1, suggest that Bon Natural Life Ltd. is trading at a discount relative to its industry counterparts.<BR><BR>Additionally, the company's recent stock performance has outpaced the Sensex, reinforcing the notion of its undervaluation. Overall, the combination of favorable ratios and peer comparisons indicates that Bon Natural Life Ltd. presents a compelling investment opportunity at its current valuation.

Read More

Is Bon Natural Life Ltd. technically bullish or bearish?

20-Sep-2025

As of September 10, 2025, Bon Natural Life Ltd. shows a neutral trend with mixed indicators, including mildly bullish weekly MACD and KST, a bearish weekly RSI, and indecisive daily moving averages.

As of 10 September 2025, the technical trend for Bon Natural Life Ltd. has changed from mildly bearish to sideways. The current stance is neutral, with mixed indicators influencing the outlook. The weekly MACD and KST are mildly bullish, while the weekly RSI is bearish. Monthly indicators show a bullish RSI but a bearish KST and Dow Theory. Daily moving averages are mildly bearish, contributing to the overall indecisiveness. There is no available multi-period return data to compare against the S&P 500.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 11 Million ()

stock-summary
P/E

12.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.15

stock-summary
Return on Equity

0.83%

stock-summary
Price to Book

0.25

Revenue and Profits:
Net Sales:
204 Million
(Quarterly Results - Sep 2005)
Net Profit:
18 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
17.76%
0%
17.76%
6 Months
0%
0%
0.0%
1 Year
-95.35%
0%
-95.35%
2 Years
-98.41%
0%
-98.41%
3 Years
67.29%
0%
67.29%
4 Years
-99.86%
0%
-99.86%
5 Years
0%
0%
0.0%

Bon Natural Life Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.80%
EBIT Growth (5y)
-10.07%
EBIT to Interest (avg)
4.64
Debt to EBITDA (avg)
0.96
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
0.84
Tax Ratio
35.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.18%
ROCE (avg)
16.19%
ROE (avg)
16.42%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
0.26
EV to EBIT
9.70
EV to EBITDA
5.77
EV to Capital Employed
0.36
EV to Sales
0.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.71%
ROE (Latest)
0.83%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Sideways
Moving Averages
Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.04%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Bon Natural Life Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2023 is -1.34% vs 17.25% in Sep 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2023 is -25.81% vs 34.78% in Sep 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'23",
        "Sep'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "29.50",
          "val2": "29.90",
          "chgp": "-1.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.10",
          "val2": "6.90",
          "chgp": "2.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.40",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.60",
          "val2": "6.20",
          "chgp": "-25.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "200.50%",
          "val2": "218.70%",
          "chgp": "-1.82%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Sep'23stock-summary
Sep'23
Sep'22
Change(%)
Net Sales
29.50
29.90
-1.34%
Operating Profit (PBDIT) excl Other Income
7.10
6.90
2.90%
Interest
0.20
0.40
-50.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
4.60
6.20
-25.81%
Operating Profit Margin (Excl OI)
200.50%
218.70%
-1.82%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Sep 2023 is -1.34% vs 17.25% in Sep 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Sep 2023 is -25.81% vs 34.78% in Sep 2022

stock-summaryCompany CV
About Bon Natural Life Ltd. stock-summary
stock-summary
Bon Natural Life Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available